LiDCO Group (LON:LID)‘s stock had its “buy” rating reiterated by equities research analysts at N+1 Singer in a research report issued on Friday. They presently have a GBX 14 ($0.19) target price on the stock. N+1 Singer’s price objective would indicate a potential upside of 108.96% from the company’s previous close.
Separately, FinnCap reissued a “corporate” rating and issued a GBX 14 ($0.19) target price on shares of LiDCO Group in a report on Tuesday, November 21st.
LiDCO Group (LON:LID) opened at GBX 6.70 ($0.09) on Friday. LiDCO Group has a twelve month low of GBX 5.50 ($0.08) and a twelve month high of GBX 10.25 ($0.14).
About LiDCO Group
LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.
Receive News & Ratings for LiDCO Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group and related companies with MarketBeat.com's FREE daily email newsletter.